Search

Home > Cell & Gene: The Podcast > Inside Spark Therapeutics' Investigational SPK-8011 for Hemophilia A
Podcast: Cell & Gene: The Podcast
Episode:

Inside Spark Therapeutics' Investigational SPK-8011 for Hemophilia A
Category: Science & Medicine
Duration: 00:19:33
Publish Date: 2021-09-30 08:00:00
Description:

Spark Therapeutics' Clinical Development Lead, Hematology, Dr. Tiffany Chang explains the company's data from its ongoing Phase 1/2 clinical trial of investigational SPK-8011 for hemophilia A, the largest gene therapy trial in this disease to date as well as the misconceptions and unknowns about the disease.
Total Play: 0